,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,155,1,1,,74110,264,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
1,157,1,1,,74110,264,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
2,161,1,1,,74110,264,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
3,165,1,1,,74110,264,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
4,167,1,1,,74110,264,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
5,175,1,1,,74110,264,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
6,192,1,1,,74110,264,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
7,200,1,1,,74110,264,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intraperitoneal) in B6C3F1 mice,Other,,
8,206,1,1,,74110,264,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  HT29;CX-1 Human Adenocarcinoma (MER+) (intrarenal inoculation) in NU/NU Swiss (nude) mice,Other,,
9,212,1,1,,74110,264,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Colon Carcinoma 38 (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
10,220,1,1,,74110,264,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Mammary Adenocarcinoma CD8F1 (subcutaneous) in CD8F1,Other,,
11,256,1,1,,74110,264,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
12,264,1,1,,74110,264,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Human Lung LX-1 Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice,Other,,
13,274,1,1,,74110,264,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (intravenous) in B6D2F1 (BDF1) mice,Other,,
14,276,1,1,,74110,264,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (intravenous) in B6C3F1 mice,Other,,
15,296,1,1,,74110,264,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Human Mammary Carcinoma MX-1 Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice,Other,,
16,330,1,1,,74110,264,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
17,1201,1,2,,48414707,264,Inactive,,,,,DSSTox (DBPCAN) EPA Water Disinfection By-Products with Carcinogenicity Estimates,Other,,
18,3329,6,2,,103176198,264,Unspecified,,,1000.0,IC50,Concentration required to inhibit the colony formation of lung carcinoma (3LLD122) cell lines by 50%,Confirmatory,10956204.0,
19,23251,3,3,,103176198,264,Unspecified,,,,,Partition coefficient (logP),Other,3599019.0,
20,23252,3,3,,103176198,264,Unspecified,,,,,Partition coefficient (logP) (benzene),Other,3599019.0,
21,23253,3,3,,103176198,264,Unspecified,,,,,Partition coefficient (logP) (carbon tetrachloride),Other,3599019.0,
22,23254,3,3,,103176198,264,Unspecified,,,,,Partition coefficient (logP) (chloroform),Other,3599019.0,
23,23255,3,3,,103176198,264,Unspecified,,,,,Partition coefficient (logP) (ether),Other,3599019.0,
24,23256,3,3,,103176198,264,Unspecified,,,,,Partition coefficient (logP) (hexane),Other,3599019.0,
25,41060,3,4,,103176198,264,Unspecified,,,,,Effect on appearance of B16F10.9 colonies in semisolid agar at 1 mM,Other,1542095.0,
26,41062,6,2,,103176198,264,Unspecified,,,933.0,IC50,Inhibitory activity on growth of B16F10.9 melanoma cell line,Confirmatory,1542095.0,
27,81291,8,1,,103176198,264,Unspecified,,,285.0,ED50,In vitro for the differentiation induction activity determined in the human myeloid leukemic cell line HL-60,Confirmatory,10956204.0,
28,81447,6,2,,103176198,264,Unspecified,,,1525.0,IC50,Concentration required for 50% proliferation inhibition of human promyelocytic HL-60 cell line,Confirmatory,1542095.0,
29,94965,3,4,,103176198,264,Unspecified,,,,,Evaluated for erythroid induction of benzidine-positive K562 cells at concentration 3 mM,Other,10560743.0,
30,95143,8,1,,103176198,264,Unspecified,,,2400.0,IC50,Inhibition of cell growth against human myeloid leukemia K562(S) cells,Confirmatory,,
31,95754,3,9,,103176198,264,Unspecified,,,,,Protein interaction energy by using binding affinity towards human L-xylulose reductase enzyme,Other,12668014.0,
32,154429,6,3,,103176198,264,Unspecified,,,250.0,IC50,Concentration required to inhibit the colony formation of pancreatic human (PACA) cell lines by 50%,Confirmatory,10956204.0,
33,217956,6,2,,103176198,264,Unspecified,,,850.0,IC50,Concentration required for 50% proliferation inhibition of myelomonocytic WEHI cell line,Confirmatory,1542095.0,
34,237685,4,3,,103176198,264,Unspecified,,,,,Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system,Other,15857133.0,
35,336938,3,5,,103176198,264,Unspecified,,,,,Inhibition of EBV-early antigen activation in human Raji cells assessed as early antigen activation at 4 mM,Other,2553872.0,
36,336939,3,5,,103176198,264,Unspecified,,,,,Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed as early antigen activation at 4 mM ratio relative to TPA,Other,2553872.0,
37,344916,6,2,,103176198,264,Unspecified,,,10000.0,IC50,Inhibition of 2-oxoglutarate-dependent human JMJD2E in presence of excess 2-oxoglutarate and 10 uM Fe2 by FDH coupled assay,Confirmatory,18942826.0,
38,344917,6,2,,103176198,264,Unspecified,,,10000.0,IC50,Inhibition of 2-oxoglutarate-dependent human JMJD2E in presence of excess H3K9me3 peptide and 10 uM Fe2 by FDH coupled assay,Confirmatory,18942826.0,
39,347392,6,2,,103176198,264,Unspecified,,,932.0,IC50,Cytotoxicity against human U251 cells after 72 hrs by Hoechst test,Confirmatory,19007111.0,
40,347396,3,4,,103176198,264,Active,,,,,Increase in ROS production in human U251 cells at 100 uM after 4 hrs by FACS,Other,19007111.0,
41,347397,3,4,,103176198,264,Active,,,,,Increase in ROS production in human U251 cells at 100 uM after 4 hrs by FACS in presence of N-acetyl-L-cysteine,Other,19007111.0,
42,347403,4,4,,103176198,264,Unspecified,,,,,Increase in heme level in human U251 cells at 100 uM after 48 hrs by Western blot relative to control,Other,19007111.0,
43,347410,3,4,,103176198,264,Active,,,,,Inhibition of 26S proteasome activity in human U251 cells at 0.5 mM after 24 hrs,Other,19007111.0,
44,347412,4,4,,103176198,264,Unspecified,,,,,Inhibition of 26S proteasome activity in human U251 cells at 100 uM after 48 hrs relative to control,Other,19007111.0,
45,347413,3,4,,103176198,264,Unspecified,,,,,Inhibition of 26S proteasome activity in human U251 cells at 100 uM after 48 hrs in presence of N-acetyl-L-cysteine relative to control,Other,19007111.0,
46,360149,11,2,,103176198,264,Unspecified,56404586.0,381203.0,81.2831,Ki,Inhibition of mouse Oat6-mediated [3H]ES uptake in Xenopus oocytes after 1 hr,Confirmatory,17553798.0,
47,360150,11,2,,103176198,264,Unspecified,81901833.0,18399.0,3467.37,Ki,Inhibition of mouse Oat1-mediated [3H]PAH uptake in Xenopus oocytes after 1 hr,Confirmatory,17553798.0,
48,360151,3,4,,103176198,264,Unspecified,,,,,Ratio of pKi for mouse Oat1 expressed in Xenopus oocytes to pKi for mouse Oat6 expressed in Xenopus oocytes,Other,17553798.0,
49,410585,3,4,,103176198,264,Unspecified,,,,,Inhibition of erythroid differentiation in human K562 cell assessed benzidine positive cells at 2 mM after 6 days by benzidine staining assay,Other,19072686.0,
50,412897,3,6,,103176198,264,Active,2498443.0,3065.0,,,Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in p21 mRNA level by qRT-PCR,Other,19053749.0,
51,412897,3,6,,103176198,264,Active,3334210.0,8841.0,,,Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in p21 mRNA level by qRT-PCR,Other,19053749.0,
52,412897,3,6,,103176198,264,Active,19865267.0,9734.0,,,Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in p21 mRNA level by qRT-PCR,Other,19053749.0,
53,412897,3,6,,103176198,264,Active,26394832.0,79885.0,,,Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in p21 mRNA level by qRT-PCR,Other,19053749.0,
54,412897,3,6,,103176198,264,Active,27734403.0,83933.0,,,Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in p21 mRNA level by qRT-PCR,Other,19053749.0,
55,412897,3,6,,103176198,264,Active,29839394.0,55869.0,,,Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in p21 mRNA level by qRT-PCR,Other,19053749.0,
56,412897,3,6,,103176198,264,Active,30913097.0,51564.0,,,Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in p21 mRNA level by qRT-PCR,Other,19053749.0,
57,412897,3,6,,103176198,264,Active,68068066.0,3066.0,,,Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in p21 mRNA level by qRT-PCR,Other,19053749.0,
58,412897,3,6,,103176198,264,Active,205371758.0,10013.0,,,Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in p21 mRNA level by qRT-PCR,Other,19053749.0,
59,412897,3,6,,103176198,264,Active,259016348.0,9759.0,,,Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in p21 mRNA level by qRT-PCR,Other,19053749.0,
60,412897,3,6,,103176198,264,Active,296434519.0,10014.0,,,Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in p21 mRNA level by qRT-PCR,Other,19053749.0,
61,412899,3,6,,103176198,264,Active,2498443.0,3065.0,,,Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in histone H3 acetylation after 3 days by densitometry,Other,19053749.0,
62,412899,3,6,,103176198,264,Active,3334210.0,8841.0,,,Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in histone H3 acetylation after 3 days by densitometry,Other,19053749.0,
63,412899,3,6,,103176198,264,Active,19865267.0,9734.0,,,Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in histone H3 acetylation after 3 days by densitometry,Other,19053749.0,
64,412899,3,6,,103176198,264,Active,26394832.0,79885.0,,,Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in histone H3 acetylation after 3 days by densitometry,Other,19053749.0,
65,412899,3,6,,103176198,264,Active,27734403.0,83933.0,,,Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in histone H3 acetylation after 3 days by densitometry,Other,19053749.0,
66,412899,3,6,,103176198,264,Active,29839394.0,55869.0,,,Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in histone H3 acetylation after 3 days by densitometry,Other,19053749.0,
67,412899,3,6,,103176198,264,Active,30913097.0,51564.0,,,Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in histone H3 acetylation after 3 days by densitometry,Other,19053749.0,
68,412899,3,6,,103176198,264,Active,68068066.0,3066.0,,,Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in histone H3 acetylation after 3 days by densitometry,Other,19053749.0,
69,412899,3,6,,103176198,264,Active,205371758.0,10013.0,,,Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in histone H3 acetylation after 3 days by densitometry,Other,19053749.0,
70,412899,3,6,,103176198,264,Active,259016348.0,9759.0,,,Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in histone H3 acetylation after 3 days by densitometry,Other,19053749.0,
71,412899,3,6,,103176198,264,Active,296434519.0,10014.0,,,Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in histone H3 acetylation after 3 days by densitometry,Other,19053749.0,
72,416474,6,2,,103176198,264,Unspecified,,,2000.0,IC50,Antiproliferative activity against human K562 cells,Confirmatory,18571290.0,
73,416475,3,4,,103176198,264,Unspecified,,,,,Induction of erythroid differentiation in human K562 cells assessed as benzidine-positive cells after 6 days,Other,18571290.0,
74,447579,8,1,,103176198,264,Unspecified,2498443.0,3065.0,,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
75,447579,8,1,,103176198,264,Unspecified,3334210.0,8841.0,,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
76,447579,8,1,,103176198,264,Unspecified,19865267.0,9734.0,,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
77,447579,8,1,,103176198,264,Unspecified,26394832.0,79885.0,,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
78,447579,8,1,,103176198,264,Unspecified,27734403.0,83933.0,,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
79,447579,8,1,,103176198,264,Unspecified,29839394.0,55869.0,,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
80,447579,8,1,,103176198,264,Unspecified,30913097.0,51564.0,,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
81,447579,8,1,,103176198,264,Unspecified,68068066.0,3066.0,,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
82,447579,8,1,,103176198,264,Unspecified,205371758.0,10013.0,,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
83,447579,8,1,,103176198,264,Unspecified,259016348.0,9759.0,,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
84,447579,8,1,,103176198,264,Unspecified,296434519.0,10014.0,,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
85,498773,2,4,,103176198,264,Unspecified,,,,,Toxicity in po dosed ICR mouse assessed as decreased in mobility after 3 hrs,Other,19465932.0,
86,498776,5,2,,103176198,264,Unspecified,,,,,Toxicity in po dosed rat,Other,19465932.0,
87,569928,7,5,,103176198,264,Active,2498443.0,3065.0,16.0,IC50,Inhibition of human recombinant HDAC1,Confirmatory,21874153.0,
88,569929,7,5,,103176198,264,Active,68068066.0,3066.0,12.0,IC50,Inhibition of human recombinant HDAC2,Confirmatory,21874153.0,
89,569930,7,5,,103176198,264,Active,3334210.0,8841.0,9.0,IC50,Inhibition of human recombinant HDAC3,Confirmatory,21874153.0,
90,569931,7,5,,103176198,264,Active,29839394.0,55869.0,15.0,IC50,Inhibition of human recombinant HDAC8,Confirmatory,21874153.0,
91,569932,5,6,,103176198,264,Unspecified,259016348.0,9759.0,2000.0,IC50,Inhibition of human recombinant HDAC4,Confirmatory,21874153.0,
92,569933,7,5,,103176198,264,Unspecified,296434519.0,10014.0,2000.0,IC50,Inhibition of human recombinant HDAC5,Confirmatory,21874153.0,
93,569934,8,5,,103176198,264,Unspecified,30913097.0,51564.0,2000.0,IC50,Inhibition of human recombinant HDAC7,Confirmatory,21874153.0,
94,569935,8,5,,103176198,264,Unspecified,19865267.0,9734.0,2000.0,IC50,Inhibition of human recombinant HDAC9,Confirmatory,21874153.0,
95,569936,7,5,,103176198,264,Unspecified,205371758.0,10013.0,2000.0,IC50,Inhibition of human recombinant HDAC6,Confirmatory,21874153.0,
96,569937,3,9,,103176198,264,Inactive,205371758.0,10013.0,,,Inhibition of HDAC6 in human HeLa cells assessed as acetylation of tubulin after 24 hrs by immunofluorescence assay,Other,21874153.0,
97,569944,3,3,,103176198,264,Inactive,,,,,Inhibition of HDAC in mouse primary forebrain neurons assessed as acetylation of histone H2A at 92.5 uM after 24 hrs by immunofluorescence assay,Other,21874153.0,
98,624611,1,9,,103176198,264,Unspecified,29839637.0,54576.0,,,Specific activity of expressed human recombinant UGT1A8,Other,10836148.0,
99,624613,1,9,,103176198,264,Unspecified,29839636.0,54575.0,,,Specific activity of expressed human recombinant UGT1A10,Other,10836148.0,
100,651631,4,1,,144209580,264,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
101,651631,4,1,,144210484,264,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
102,651632,4,1,,144209580,264,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
103,651632,4,1,,144210484,264,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
104,651633,4,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
105,651633,4,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
106,651634,4,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
107,651634,4,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
108,682070,1,7,,103176198,264,Unspecified,1709076.0,25027.0,,,TP_TRANSPORTER: uptake of Butyric acid at a concentration of 137uM in MCT1-expressing MDA-MB231 cells,Other,10579682.0,
109,720516,2,1,,144209580,264,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
110,720516,2,1,,144210484,264,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
111,720552,2,1,,144209580,264,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
112,720552,2,1,,144210484,264,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
113,720634,2,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
114,720634,2,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
115,720635,2,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
116,720635,2,1,,144210484,264,Inconclusive,,,1.5355,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
117,720637,2,1,,144209580,264,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
118,720637,2,1,,144210484,264,Inconclusive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
119,720674,2,2,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
120,720674,2,2,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
121,720675,2,2,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
122,720675,2,2,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
123,720678,2,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
124,720678,2,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
125,720679,2,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
126,720679,2,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
127,720680,2,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
128,720680,2,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
129,720681,2,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
130,720681,2,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
131,720682,2,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
132,720682,2,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
133,720683,2,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
134,720683,2,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
135,720684,2,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
136,720684,2,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
137,720685,2,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
138,720685,2,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
139,720686,2,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
140,720686,2,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
141,720687,2,2,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
142,720687,2,2,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
143,720691,4,1,,144209580,264,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
144,720691,4,1,,144210484,264,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
145,720692,3,1,,144209580,264,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
146,720692,3,1,,144210484,264,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
147,720693,3,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
148,720693,3,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
149,720719,2,1,,144209580,264,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
150,720719,2,1,,144210484,264,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
151,720725,2,1,,144209580,264,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
152,720725,2,1,,144210484,264,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
153,743012,3,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
154,743012,3,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
155,743014,3,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
156,743014,3,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
157,743015,3,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
158,743015,3,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
159,743033,3,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
160,743033,3,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
161,743035,2,1,,144209580,264,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
162,743035,2,1,,144210484,264,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
163,743036,2,1,,144209580,264,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
164,743036,2,1,,144210484,264,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
165,743040,3,1,,144209580,264,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
166,743040,3,1,,144210484,264,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
167,743041,3,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
168,743041,3,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
169,743042,3,1,,144209580,264,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
170,743042,3,1,,144210484,264,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
171,743053,2,1,,144209580,264,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
172,743053,2,1,,144210484,264,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
173,743054,2,1,,144209580,264,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
174,743054,2,1,,144210484,264,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
175,743063,2,1,,144209580,264,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
176,743063,2,1,,144210484,264,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
177,743064,3,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
178,743064,3,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
179,743065,3,1,,144209580,264,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
180,743065,3,1,,144210484,264,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
181,743066,3,1,,144209580,264,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
182,743066,3,1,,144210484,264,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
183,743067,2,1,,144209580,264,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
184,743067,2,1,,144210484,264,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
185,743069,2,1,,144209580,264,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
186,743069,2,1,,144210484,264,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
187,743074,2,1,,144209580,264,Inconclusive,,,8.163,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
188,743074,2,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
189,743075,2,1,,144209580,264,Inconclusive,348019627.0,2099.0,20.5046,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
190,743075,2,1,,144210484,264,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
191,743077,2,1,,144209580,264,Inconclusive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
192,743077,2,1,,144210484,264,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
193,743078,2,1,,144209580,264,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
194,743078,2,1,,144210484,264,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
195,743079,3,1,,144209580,264,Inconclusive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
196,743079,3,1,,144210484,264,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
197,743080,3,1,,144209580,264,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
198,743080,3,1,,144210484,264,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
199,743081,3,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
200,743081,3,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
201,743083,3,1,,144209580,264,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
202,743083,3,1,,144210484,264,Inactive,119597822.0,1588.0,68.5896,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
203,743084,3,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
204,743084,3,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
205,743085,3,1,,144209580,264,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
206,743085,3,1,,144210484,264,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
207,743086,3,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
208,743086,3,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
209,743091,2,1,,144209580,264,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
210,743091,2,1,,144210484,264,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
211,743094,3,1,,144209580,264,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
212,743094,3,1,,144210484,264,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
213,743122,2,1,,144209580,264,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
214,743122,2,1,,144210484,264,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
215,743139,2,1,,144209580,264,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
216,743139,2,1,,144210484,264,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
217,743140,2,1,,144209580,264,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
218,743140,2,1,,144210484,264,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
219,743191,3,1,,144209580,264,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
220,743191,3,1,,144210484,264,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
221,743194,3,1,,144209580,264,Inconclusive,,,7.2753,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
222,743194,3,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
223,743199,2,1,,144209580,264,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
224,743199,2,1,,144210484,264,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
225,743202,4,1,,144209580,264,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
226,743202,4,1,,144210484,264,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
227,743203,3,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
228,743203,3,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
229,743209,3,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
230,743209,3,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
231,743210,4,1,,144209580,264,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
232,743210,4,1,,144210484,264,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
233,743211,3,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
234,743211,3,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
235,743212,3,1,,144209580,264,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
236,743212,3,1,,144210484,264,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
237,743213,3,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
238,743213,3,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
239,743215,3,1,,144209580,264,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
240,743215,3,1,,144210484,264,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
241,743217,3,1,,144209580,264,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
242,743217,3,1,,144210484,264,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
243,743218,3,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
244,743218,3,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
245,743219,3,1,,144209580,264,Inconclusive,20149576.0,4780.0,57.3205,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
246,743219,3,1,,144210484,264,Inactive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
247,743220,3,1,,144209580,264,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
248,743220,3,1,,144210484,264,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
249,743221,3,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
250,743221,3,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
251,743222,3,1,,144209580,264,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
252,743222,3,1,,144210484,264,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
253,743223,3,1,,144209580,264,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
254,743223,3,1,,144210484,264,Inconclusive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
255,743224,3,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
256,743224,3,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
257,743225,3,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
258,743225,3,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
259,743226,2,1,,144209580,264,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
260,743226,2,1,,144210484,264,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
261,743227,2,1,,144209580,264,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
262,743227,2,1,,144210484,264,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
263,743228,3,1,,144209580,264,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
264,743228,3,1,,144210484,264,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
265,743239,2,1,,144209580,264,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
266,743239,2,1,,144210484,264,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
267,743240,2,1,,144209580,264,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
268,743240,2,1,,144210484,264,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
269,743241,2,1,,144209580,264,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
270,743241,2,1,,144210484,264,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
271,743242,2,1,,144209580,264,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
272,743242,2,1,,144210484,264,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
273,977610,3,1,,46393305,264,Active,50513824.0,,1300.0,Ki,Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB,Other,14717710.0,
274,977610,3,1,,46393305,264,Active,50513825.0,,1300.0,Ki,Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB,Other,14717710.0,
275,977611,3,1,,208012636,264,Active,,,24.1,Kd,Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB,Other,23149273.0,
276,1081607,1,1,,103176198,264,Active,,,,,"Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as seed germination at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to 1,8-Cineole",Other,20715837.0,
277,1081608,1,1,,103176198,264,Active,,,,,"Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as shoot length at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to 1,8-Cineole",Other,20715837.0,
278,1081609,1,1,,103176198,264,Active,,,,,"Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as root length at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to 1,8-Cineole",Other,20715837.0,
279,1081610,1,1,,103176198,264,Active,,,,,"Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as seed germination at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to 1,8-Cineole",Other,20715837.0,
280,1081611,1,1,,103176198,264,Active,,,,,"Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as shoot length at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to 1,8-Cineole",Other,20715837.0,
281,1081612,1,1,,103176198,264,Active,,,,,"Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as root length at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to 1,8-Cineole",Other,20715837.0,
282,1081616,1,1,,103176198,264,Unspecified,,,,,Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as seed germination at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to control,Other,20715837.0,
283,1081617,1,1,,103176198,264,Unspecified,,,,,Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as shoot length at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to control,Other,20715837.0,
284,1081618,1,1,,103176198,264,Unspecified,,,,,Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as root length at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to control,Other,20715837.0,
285,1081622,1,1,,103176198,264,Unspecified,,,,,Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as seed germination at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to control,Other,20715837.0,
286,1081623,1,1,,103176198,264,Unspecified,,,,,Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as shoot length at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to control,Other,20715837.0,
287,1081625,1,1,,103176198,264,Unspecified,,,,,Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as root length at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to control,Other,20715837.0,
288,1081637,1,1,,103176198,264,Unspecified,,,,,Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as concentration required to suppress shoot growth at 25 degC after 72 hr by laboratory-based agar medium bioassay,Other,20715837.0,
289,1081638,1,1,,103176198,264,Unspecified,,,,,Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as concentration required to suppress seed germination at 25 degC after 72 hr by laboratory-based agar medium bioassay,Other,20715837.0,
290,1081639,1,1,,103176198,264,Unspecified,,,,,Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as concentration required to suppress root growth at 25 degC after 72 hr by laboratory-based agar medium bioassay,Other,20715837.0,
291,1081640,1,1,,103176198,264,Unspecified,,,,,Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as concentration required to suppress seed germination at 25 degC after 72 hr by laboratory-based agar medium bioassay,Other,20715837.0,
292,1081641,1,1,,103176198,264,Unspecified,,,,,Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as concentration required to suppress shoot growth at 25 degC after 72 hr by laboratory-based agar medium bioassay,Other,20715837.0,
293,1081642,1,1,,103176198,264,Unspecified,,,,,Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as concentration required to suppress root growth at 25 degC after 72 hr by laboratory-based agar medium bioassay,Other,20715837.0,
294,1081753,3,1,,103176198,264,Unspecified,,,,,Nematicidal activity against Meloidogyne incognita J2 (root-knot nematode) assessed as paralysis measured at 500 ug/mL by fumigant assay,Other,20925380.0,
295,1081754,1,1,,103176198,264,Unspecified,,,,,Nematicidal activity against Meloidogyne incognita J2 (root-knot nematode) assessed as paralysis measured after 1 day at 28 degC,Other,20925380.0,
296,1081755,1,1,,103176198,264,Unspecified,,,,,Nematicidal activity against Meloidogyne incognita J2 (root-knot nematode) assessed as paralysis measured after 1 hr at 28 degC,Other,20925380.0,
297,1083120,1,1,,103176198,264,Unspecified,,,,,Nematicidal activity against second-stage juvenile of Meloidogyne incognita (root-knot nematode) assessed as mortality at 25 degC at 2000 umol/L after 24 hr Rvb = 1.47 to 2.51%),Other,23121218.0,
298,1083121,1,1,,103176198,264,Unspecified,,,,,Nematicidal activity against second-stage juvenile of Meloidogyne incognita (root-knot nematode) assessed as mortality at 25 degC at 2000 umol/L after 12 hr (Rvb = 1.79 to 3.30%),Other,23121218.0,
299,1083122,1,1,,103176198,264,Unspecified,,,,,Nematicidal activity against second-stage juvenile of Meloidogyne incognita (root-knot nematode) assessed as mortality at 25 degC at 1000 umol/L after 24 hr Rvb = 1.47 to 2.51%),Other,23121218.0,
300,1083123,1,1,,103176198,264,Unspecified,,,,,Nematicidal activity against second-stage juvenile of Meloidogyne incognita (root-knot nematode) assessed as mortality at 25 degC at 1000 umol/L after 12 hr (Rvb = 1.79 to 3.30%),Other,23121218.0,
301,1083124,1,1,,103176198,264,Unspecified,,,,,Nematicidal activity against second-stage juvenile of Meloidogyne incognita (root-knot nematode) assessed as mortality at 25 degC at 100 umol/L after 24 hr (Rvb = 1.47 to 2.51%),Other,23121218.0,
302,1083125,1,1,,103176198,264,Unspecified,,,,,Nematicidal activity against second-stage juvenile of Meloidogyne incognita (root-knot nematode) assessed as mortality at 25 degC at 100 umol/L after 12 hr (Rvb = 1.79 to 3.30%),Other,23121218.0,
303,1083126,1,1,,103176198,264,Unspecified,,,,,Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 2000 umol/L on day 21 (SDW control = 44.87 +/- 3.93%),Other,23121218.0,
304,1083127,1,1,,103176198,264,Unspecified,,,,,Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 1000 umol/L on day 21 (SDW control = 44.87 +/- 3.93%),Other,23121218.0,
305,1083128,1,1,,103176198,264,Unspecified,,,,,Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 100 umol/L on day 21 (SDW control = 44.87 +/- 3.93%),Other,23121218.0,
306,1083129,1,1,,103176198,264,Unspecified,,,,,Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 2000 umol/L on day 14 (SDW control = 35.77 +/- 4.48%),Other,23121218.0,
307,1083130,1,1,,103176198,264,Unspecified,,,,,Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 1000 umol/L on day 14 (SDW control = 35.77 +/- 4.48%),Other,23121218.0,
308,1083131,1,1,,103176198,264,Unspecified,,,,,Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 100 umol/L on day 14 (SDW control = 35.77 +/- 4.48%),Other,23121218.0,
309,1083132,1,1,,103176198,264,Unspecified,,,,,Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 2000 umol/L on day 7 (SDW control = 12.63 +/- 3.84%),Other,23121218.0,
310,1083133,1,1,,103176198,264,Unspecified,,,,,Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 1000 umol/L on day 7 (SDW control = 12.63 +/- 3.84%),Other,23121218.0,
311,1083134,1,1,,103176198,264,Unspecified,,,,,Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 100 umol/L on day 7 (SDW control = 12.63 +/- 3.84%),Other,23121218.0,
312,1083135,1,1,,103176198,264,Unspecified,,,,,Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 2000 umol/L on day 3 (SDW control = 0.57 +/- 0.37%),Other,23121218.0,
313,1083136,1,1,,103176198,264,Unspecified,,,,,Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 1000 umol/L on day 3 (SDW control = 0.57 +/- 0.37%),Other,23121218.0,
314,1083137,1,1,,103176198,264,Unspecified,,,,,Nematicidal activity against Meloidogyne incognita (root-knot nematode) root-knot nematodes assessed as cumulative percentage of egg hatching at 25 degC at 100 umol/L on day 3 (SDW control = 0.57 +/- 0.37%),Other,23121218.0,
315,1083149,1,1,,103176198,264,Unspecified,,,,,Nematotoxic activity against freshly hatched Meloidogyne incognita J2 (root-knot nematode) isolated from tomato roots assessed as induction of nematode paralysis measured 24 hr after immersion in compound test solutions,Other,23136941.0,
316,1134605,2,1,,103176198,264,Unspecified,,,,,"Oil-water partition coefficient, log P of the compound",Other,894678.0,
317,1134606,2,1,,103176198,264,Unspecified,,,,,"Et2O-water partition coefficient, log P of the compound",Other,894678.0,
318,1159509,1,1,,144209580,264,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
319,1159509,1,1,,144210484,264,Inconclusive,119626539.0,4790.0,0.6917,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
320,1159515,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
321,1159515,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
322,1159516,1,1,,144209580,264,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
323,1159516,1,1,,144210484,264,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
324,1159517,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
325,1159517,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
326,1159518,1,1,,144209580,264,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
327,1159518,1,1,,144210484,264,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
328,1159519,1,1,,144209580,264,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
329,1159519,1,1,,144210484,264,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
330,1159520,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
331,1159520,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
332,1159521,1,1,,144209580,264,Inactive,15928672.0,19885.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
333,1159521,1,1,,144210484,264,Inactive,15928672.0,19885.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
334,1159523,1,1,,144209580,264,Inactive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
335,1159523,1,1,,144210484,264,Inactive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
336,1159525,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
337,1159525,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
338,1159526,1,1,,144209580,264,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
339,1159526,1,1,,144210484,264,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
340,1159527,1,1,,144209580,264,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
341,1159527,1,1,,144210484,264,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
342,1159528,1,1,,144209580,264,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
343,1159528,1,1,,144210484,264,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
344,1159529,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
345,1159529,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
346,1159531,1,1,,144209580,264,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
347,1159531,1,1,,144210484,264,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
348,1159551,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
349,1159551,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
350,1159552,1,1,,144209580,264,Inactive,325495463.0,5914.0,72.1622,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
351,1159552,1,1,,144210484,264,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
352,1159553,2,1,,144209580,264,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
353,1159553,2,1,,144210484,264,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
354,1159555,1,1,,144209580,264,Inconclusive,325495463.0,5914.0,14.3982,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
355,1159555,1,1,,144210484,264,Inactive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
356,1224834,3,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
357,1224834,3,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
358,1224835,1,1,,144209580,264,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
359,1224835,1,1,,144210484,264,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
360,1224836,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
361,1224836,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
362,1224837,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
363,1224837,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
364,1224838,1,1,,144209580,264,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
365,1224838,1,1,,144210484,264,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
366,1224839,1,1,,144209580,264,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
367,1224839,1,1,,144210484,264,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
368,1224840,3,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
369,1224840,3,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
370,1224841,3,1,,144209580,264,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
371,1224841,3,1,,144210484,264,Inactive,325495545.0,2101.0,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
372,1224842,3,1,,144209580,264,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
373,1224842,3,1,,144210484,264,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
374,1224843,1,1,,144209580,264,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
375,1224843,1,1,,144210484,264,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
376,1224844,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
377,1224844,1,1,,144210484,264,Inconclusive,,,17.3739,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
378,1224845,1,1,,144209580,264,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
379,1224845,1,1,,144210484,264,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
380,1224846,1,1,,144209580,264,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
381,1224846,1,1,,144210484,264,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
382,1224847,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
383,1224847,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
384,1224848,3,1,,144209580,264,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
385,1224848,3,1,,144210484,264,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
386,1224849,3,1,,144209580,264,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
387,1224849,3,1,,144210484,264,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
388,1224867,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
389,1224867,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
390,1224868,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
391,1224868,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
392,1224869,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
393,1224869,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
394,1224870,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
395,1224870,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
396,1224871,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
397,1224871,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
398,1224872,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
399,1224872,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
400,1224873,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
401,1224873,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
402,1224874,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
403,1224874,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
404,1224875,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
405,1224875,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
406,1224876,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
407,1224876,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
408,1224877,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
409,1224877,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
410,1224878,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
411,1224878,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
412,1224879,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
413,1224879,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
414,1224880,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
415,1224880,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
416,1224881,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
417,1224881,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
418,1224882,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
419,1224882,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
420,1224883,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
421,1224883,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
422,1224884,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
423,1224884,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
424,1224885,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
425,1224885,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
426,1224886,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
427,1224886,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
428,1224887,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
429,1224887,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
430,1224888,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
431,1224888,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
432,1224889,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
433,1224889,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
434,1224890,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
435,1224890,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
436,1224892,1,1,,144209580,264,Inconclusive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
437,1224892,1,1,,144210484,264,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
438,1224893,1,1,,144209580,264,Inconclusive,66775687.0,9970.0,24.1718,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
439,1224893,1,1,,144210484,264,Inactive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
440,1224894,1,1,,144209580,264,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
441,1224894,1,1,,144210484,264,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
442,1224895,1,1,,144209580,264,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
443,1224895,1,1,,144210484,264,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
444,1224896,1,1,,144209580,264,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
445,1224896,1,1,,144210484,264,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
446,1259241,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
447,1259241,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
448,1259242,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
449,1259242,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
450,1259243,1,1,,144209580,264,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
451,1259243,1,1,,144210484,264,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
452,1259244,1,1,,144209580,264,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
453,1259244,1,1,,144210484,264,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
454,1259247,1,1,,144209580,264,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
455,1259247,1,1,,144210484,264,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
456,1259248,1,1,,144209580,264,Inconclusive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
457,1259248,1,1,,144210484,264,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
458,1259364,1,1,,144209580,264,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
459,1259364,1,1,,144210484,264,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
460,1259365,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
461,1259365,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
462,1259366,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
463,1259366,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
464,1259367,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
465,1259367,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
466,1259368,1,1,,144209580,264,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
467,1259368,1,1,,144210484,264,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
468,1259369,1,1,,144209580,264,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
469,1259369,1,1,,144210484,264,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
470,1259377,1,1,,144209580,264,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
471,1259377,1,1,,144210484,264,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
472,1259378,1,1,,144209580,264,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
473,1259378,1,1,,144210484,264,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
474,1259379,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
475,1259379,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
476,1259380,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
477,1259380,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
478,1259381,1,1,,144209580,264,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
479,1259381,1,1,,144210484,264,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
480,1259382,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
481,1259382,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
482,1259383,1,1,,144209580,264,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
483,1259383,1,1,,144210484,264,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
484,1259384,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
485,1259384,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
486,1259385,1,1,,144209580,264,Inconclusive,119601739.0,7253.0,72.1622,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
487,1259385,1,1,,144210484,264,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
488,1259386,1,1,,144209580,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
489,1259386,1,1,,144210484,264,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
490,1259387,1,1,,144209580,264,Inconclusive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
491,1259387,1,1,,144210484,264,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
492,1259388,1,1,,144209580,264,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
493,1259388,1,1,,144210484,264,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
494,1259390,1,1,,144209580,264,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
495,1259390,1,1,,144210484,264,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
496,1259391,1,1,,144209580,264,Inconclusive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
497,1259391,1,1,,144210484,264,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
498,1259392,1,1,,144209580,264,Inactive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
499,1259392,1,1,,144210484,264,Inactive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
500,1259393,1,1,,144209580,264,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
501,1259393,1,1,,144210484,264,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
502,1259394,1,1,,144209580,264,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
503,1259394,1,1,,144210484,264,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
504,1259395,1,1,,144209580,264,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
505,1259395,1,1,,144210484,264,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
506,1259396,1,1,,144209580,264,Inconclusive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
507,1259396,1,1,,144210484,264,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
508,1259401,1,1,,144209580,264,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
509,1259401,1,1,,144210484,264,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
510,1259402,1,1,,144209580,264,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
511,1259402,1,1,,144210484,264,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
512,1259403,1,1,,144209580,264,Inconclusive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
513,1259403,1,1,,144210484,264,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
514,1259404,1,1,,144209580,264,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
515,1259404,1,1,,144210484,264,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
516,1259407,1,1,,363904502,264,Inactive,,,,,CCRIS mutagenicity studies,Other,,
517,1259416,1,2,,340084279,264,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
518,1259416,1,2,,375174637,264,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
519,1259421,1,1,,340084279,264,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
520,1259421,1,1,,375174637,264,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
